« Innovation is in the DNA of Picotech »

Picotech is a French startup founded by 3 physicists from CERN, after decades of research. They have come together in 2017 for a common mission: becoming a worldwide reference in the early diagnosis of prostate cancer.

Picotech develops detector modules that improve the precision in the medical imaging. These modules allow an early diagnosis of cancer. Picotech is particularly focused on prostate cancer. This cancer is the most frequent type of cancer for men in France and the second cause of cancer death in Europe. The yearly cost of prostate cancer for health services in EU is 9 B€. 

Picotech benefits from its patented innovative technology. This allows Picotech to produce its first organ specific PET detector to prevent the unnecessary death caused by late detection of the prostate cancer and decrease the costs imposed on the health services.